Neural Precursor Cell Expressed, Developmentally Down-Regulated 9 (NEDD9) Peptide
Quick Overview for Neural Precursor Cell Expressed, Developmentally Down-Regulated 9 (NEDD9) Peptide (ABIN980595)
Target
Origin
Source
Application
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-NEDD9 antibody (Catalog #: ARP51210_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- NEDD9 (Neural Precursor Cell Expressed, Developmentally Down-Regulated 9 (NEDD9))
-
Background
-
Variation in NEDD9 is associated wih susceptibility to late-onset Alzheimer and Parkinson diseases. Changes in expression of the scaffold protein HEF1/CAS-L/NEDD9 were found to be a potent prometastatic stimulus in melanoma and other cancers.
Alias Symbols: CAS-L, CASL, HEF1, dJ49G10.2, dJ761I2.1, CAS2, CASS2
Protein Interaction Partner: FZR1,SMAD3,ABL1,BCAR1,BCAR3,CDH1,CHAT,CRK,CRKL,DIMT1L,ELSPBP1,FYN,ID2,ITCH,LCK,LYN,MICAL1,NCK1,NEDD9,PTK2,PTK2B,PTPN11,PTPN12,PXN,RAPGEF1,SH2D3C,SMAD1,SMAD2,SMAD3,TCF3,TRIP6,ZYX,ABL1,BCAR1,BCAR3,CDH1,CRK,CRKL,ELSPBP1,FYN,ID2,ITCH,LCK,LYN,MICAL1,NCK1,NEDD9,PTK2,PTK2B,PTPN12,PXN,RAPGEF1,SH2D3C,SMAD1,SMAD2,SMAD3,TRIP6,ZYX
Protein Size: 834 -
Molecular Weight
- 93 kDa
-
Gene ID
- 4739
-
NCBI Accession
- NM_006403, NP_006394
-
UniProt
- Q14511
Target
-